InsiderClue
Insiders · Profile

GUSTAFSON KURT A

Director at Xencor · Executive VP, Finance and CFO at OmniAb · Vice President and CFO at HALOZYME THERAPEUTICS. Filing since 9 Aug 2011. CIK 0001462354

XNCR Xencor Inc Director · 4 trades OABI OmniAb, Inc. Executive VP, Finance and CFO · 12 trades HALO HALOZYME THERAPEUTICS, INC. Vice President and CFO · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
XNCR Xencor Inc
15 Jun 2026
Director
Sold on a plan
5,474
$67.38K
27.1%
OABI OmniAb, Inc.
7 Apr 2026
Executive VP, Finance and CFO
Sold at will
6,913
$10.30K
2.6%
OABI OmniAb, Inc.
18 Feb 2026
Executive VP, Finance and CFO
Sold at will
9,301
$15.90K
3.3%
OABI OmniAb, Inc.
17 Feb 2026
Executive VP, Finance and CFO
Sold at will
6,828
$11.61K
2.6%
OABI OmniAb, Inc.
8 Dec 2025
Executive VP, Finance and CFO
Sold at will
23,922
$46.89K
8.6%
XNCR Xencor Inc
16 Jun 2025
Director
Sold on a plan
2,993
$27.60K
12.9%
OABI OmniAb, Inc.
7 Apr 2025
Executive VP, Finance and CFO
Sold at will
7,206
$14.41K
3.1%
OABI OmniAb, Inc.
1 Apr 2025
Executive VP, Finance and CFO
Sold at will
11,963
$28.35K
5.2%
OABI OmniAb, Inc.
19 Feb 2025
Executive VP, Finance and CFO
Sold at will
7,255
$26.63K
3.4%
OABI OmniAb, Inc.
21 Jan 2025
Executive VP, Finance and CFO
Sold at will
15,526
$50.30K
6.8%
OABI OmniAb, Inc.
9 Dec 2024
Executive VP, Finance and CFO
Sold at will
23,871
$98.59K
10.6%
XNCR Xencor Inc
27 Sep 2024
Director
Sold at will
2,503
$51.76K
20.9%
OABI OmniAb, Inc.
8 Apr 2024
Executive VP, Finance and CFO
Sold at will
6,954
$36.65K
3.8%
OABI OmniAb, Inc.
1 Apr 2024
Executive VP, Finance & CFO
Sold at will
11,849
$64.70K
6.5%
XNCR Xencor Inc
6 Mar 2024
Director
Sold at will
14,000
$324.45K
70.0%
OABI OmniAb, Inc.
28 Nov 2022
EVP, Finance and CFO
Bought
10,000
$28.10K
6.2%
HALO HALOZYME THERAPEUTICS, INC.
9 Aug 2011
Vice President and CFO
Bought
8,000
$47.01K
opened
17 decisions on file.